These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A shot of hope. Carmichael M Newsweek; 2007 Oct; 150(14):50-1, 54, 58-60 passim. PubMed ID: 17970238 [No Abstract] [Full Text] [Related]
7. Drive to vaccinate children in developing countries faces "acute crisis" because of high costs. Moszynski P BMJ; 2010 May; 340():c2576. PubMed ID: 20462931 [No Abstract] [Full Text] [Related]
8. Oral vaccines: new needs, new possibilities. Aziz MA; Midha S; Waheed SM; Bhatnagar R Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389 [TBL] [Abstract][Full Text] [Related]
9. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. Jadhav S; Datla M; Kreeftenberg H; Hendriks J Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742 [TBL] [Abstract][Full Text] [Related]
10. Vaccine venture boosts health hopes. Butler D Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588 [No Abstract] [Full Text] [Related]
11. Vaccine candidates for poor nations are going to waste. Kaslow DC; Black S; Bloom DE; Datla M; Salisbury D; Rappuoli R Nature; 2018 Dec; 564(7736):337-339. PubMed ID: 30560957 [No Abstract] [Full Text] [Related]
12. [Insufficient vaccination is a threat against world health]. Gjersvik PJ Tidsskr Nor Laegeforen; 2003 Mar; 123(6):831. PubMed ID: 12693127 [No Abstract] [Full Text] [Related]
13. [Tropical vaccinology at the dawn of the 21st century]. Plotkin S Med Trop (Mars); 2007 Aug; 67(4):320. PubMed ID: 17926787 [No Abstract] [Full Text] [Related]
15. StatBite: WHO funding and the burden of disease in the Western Pacific region. J Natl Cancer Inst; 2009 Feb; 101(3):135. PubMed ID: 19176459 [No Abstract] [Full Text] [Related]
16. [Forgotten diseases and new drugs]. Tonby K Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2694-6. PubMed ID: 17057783 [No Abstract] [Full Text] [Related]
17. Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil. Ho PL; Miyaji EN; Oliveira ML; Dias Wde O; Kubrusly FS; Tanizaki MM; Martins EA; Raw I PLoS Negl Trop Dis; 2011 Nov; 5(11):e1300. PubMed ID: 22140586 [No Abstract] [Full Text] [Related]
18. The impact of globalization on vaccine development and availability. Milstien JB; Kaddar M; Kieny MP Health Aff (Millwood); 2006; 25(4):1061-9. PubMed ID: 16835187 [TBL] [Abstract][Full Text] [Related]
19. The problems and promise of vaccine markets in developing countries. Batson A Health Aff (Millwood); 2005; 24(3):690-3. PubMed ID: 15886160 [TBL] [Abstract][Full Text] [Related]
20. Government action needed to step up research and development for world's most neglected diseases. Pecoul B Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495 [No Abstract] [Full Text] [Related] [Next] [New Search]